Rebutting pharma’s rejection of a global COVID-19 IP waiver

In response to the COVID-19 “TRIPS waiver” proposal submitted by South Africa and India for a temporary waiver from certain pharmaceutical intellectual property (IP) obligations at the World Trade Organization (WTO), Thomas Cueni, the director-general of the International Federation of Pharmaceutical Manufacturers and…

With the recent postponement of the World Trade Organization (WTO) Ministerial Conference in Geneva, uncertainty swirls around the fate of the WTO TRIPS Waiver on intellectual property of COVID-19 medical tools, which was to have been central to the ministerial discussions and the culmination of many months of mobilisation and…

MSF Access Campaign — Medicines Are Not a Luxury

This blog is a place to reflect on our experiences working for access to medicines. For the official MSF Access Campaign website please visit msfaccess.org.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store